91 related articles for article (PubMed ID: 23448676)
1. Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2013 Jun; 20(6):942-8. PubMed ID: 23448676
[TBL] [Abstract][Full Text] [Related]
2. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia and risk of cancer: a population-based case-control study.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 May; 21(5):773-8. PubMed ID: 24571170
[TBL] [Abstract][Full Text] [Related]
4. Use of azathioprine and the risk of cancer in inflammatory bowel disease.
Pasternak B; Svanström H; Schmiegelow K; Jess T; Hviid A
Am J Epidemiol; 2013 Jun; 177(11):1296-305. PubMed ID: 23514635
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
Rawoot A; Little F; Heckmann JM
S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
[No Abstract] [Full Text] [Related]
6. [Abscess of the thyroid gland caused by Salmonella enteritidis in immunosuppressive treatment of generalized myasthenia gravis with thymoma].
Zimmermann CW; Lingenfelser T; Melms A; Jakober B
Nervenarzt; 1990 Oct; 61(10):626-8. PubMed ID: 2274096
[TBL] [Abstract][Full Text] [Related]
7. Use of disulfiram and risk of cancer: a population-based case-control study.
Askgaard G; Friis S; Hallas J; Thygesen LC; Pottegård A
Eur J Cancer Prev; 2014 May; 23(3):225-32. PubMed ID: 23863824
[TBL] [Abstract][Full Text] [Related]
8. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
Zhang Z; Wang M; Xu L; Jiang B; Jin T; Shi T; Xu B
J Clin Neurosci; 2021 Jun; 88():70-74. PubMed ID: 33992207
[TBL] [Abstract][Full Text] [Related]
9. Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.
Pedersen EG; Hallas J; Pottegård A; Hald SM; Jensen PEH; Gaist D
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):486-493. PubMed ID: 29732733
[TBL] [Abstract][Full Text] [Related]
10. Extrathymic malignancies in thymoma patients with and without myasthenia gravis.
Owe JF; Cvancarova M; Romi F; Gilhus NE
J Neurol Sci; 2010 Mar; 290(1-2):66-9. PubMed ID: 20034637
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis in children: a longitudinal study.
Ashraf VV; Taly AB; Veerendrakumar M; Rao S
Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
[TBL] [Abstract][Full Text] [Related]
12. Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
McGurgan IJ; McGuigan C
Brain Behav; 2015 Oct; 5(10):e00396. PubMed ID: 26516615
[TBL] [Abstract][Full Text] [Related]
13. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
14. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study.
Armstrong RG; West J; Card TR
Am J Gastroenterol; 2010 Jul; 105(7):1604-9. PubMed ID: 20104215
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].
Kumagai M; Kondou T; Handa M; Shiraishi Y; Fujimura S; Nakata T
Kyobu Geka; 1990 Mar; 43(3):231-5. PubMed ID: 2319723
[TBL] [Abstract][Full Text] [Related]
16. [A case of thymoma with myasthenia gravis and pure red cell aplasia treated with thymectomy and azathioprine (author's transl)].
Arimori S; Nakata Y; Tada S; Kobashi H; Koriyama K; Ichikawa Y; Mitsuhashi A; Iwasaki I; Hiraki K
Nihon Naika Gakkai Zasshi; 1978 Apr; 67(4):416-22. PubMed ID: 659948
[No Abstract] [Full Text] [Related]
17. Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study.
Verwijst J; Westerberg E; Punga AR
Eur J Neurol; 2021 May; 28(5):1706-1715. PubMed ID: 33427389
[TBL] [Abstract][Full Text] [Related]
18. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
Floyd A; Pedersen L; Nielsen GL; Thorlacius-Ussing O; Sorensen HT
Am J Gastroenterol; 2003 Jun; 98(6):1305-8. PubMed ID: 12818274
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy increases the risk of cranial meningioma.
Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
[TBL] [Abstract][Full Text] [Related]
20. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
